NDC 0944-2511

HYQVIA

Immune Globulin 10 Percent (human) With Recombinant Human Hyaluronidase

HYQVIA is a Kit in the Plasma Derivative category. It is labeled and distributed by Baxalta Us Inc.. The primary component is .

Product ID0944-2511_1283c294-04ea-4a13-80b4-37e3a023ceca
NDC0944-2511
Product TypePlasma Derivative
Proprietary NameHYQVIA
Generic NameImmune Globulin 10 Percent (human) With Recombinant Human Hyaluronidase
Dosage FormKit
Marketing Start Date2014-09-12
Marketing CategoryBLA / BLA
Application NumberBLA125402
Labeler NameBaxalta US Inc.
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0944-2511-02

1 KIT in 1 CARTON (0944-2511-02) * 50 mL in 1 VIAL, GLASS (0944-2716-05) * 2.5 mL in 1 VIAL, GLASS (0944-2721-03)
Marketing Start Date2014-09-12
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0944-2511-02 [00944251102]

HYQVIA KIT
Marketing CategoryBLA
Application NumberBLA125402
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2014-09-12

Drug Details

NDC Crossover Matching brand name "HYQVIA" or generic name "Immune Globulin 10 Percent (human) With Recombinant Human Hyaluronidase"

NDCBrand NameGeneric Name
0944-2510HYQVIAImmune Globulin 10 percent (Human) with Recombinant Human Hyaluronidase
0944-2511HYQVIAImmune Globulin 10 percent (Human) with Recombinant Human Hyaluronidase
0944-2512HYQVIAImmune Globulin 10 percent (Human) with Recombinant Human Hyaluronidase
0944-2513HYQVIAImmune Globulin 10 percent (Human) with Recombinant Human Hyaluronidase
0944-2514HYQVIAImmune Globulin 10 percent (Human) with Recombinant Human Hyaluronidase

Trademark Results [HYQVIA]

Mark Image

Registration | Serial
Company
Trademark
Application Date
HYQVIA
HYQVIA
86348519 4774188 Live/Registered
BAXALTA INCORPORATED
2014-07-25
HYQVIA
HYQVIA
85239796 4669391 Live/Registered
BAXALTA INCORPORATED
2011-02-11

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.